Enteral Syringe Market By Type (Reusable, Disposable), By Age Group (Adults, Pediatrics) By End User (Hospitals, Ambulatory Surgical Centers, Homecare) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The global enteral syringe market was valued at $383.6 million in 2023, and is projected to reach $643.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.
An enteral syringe is a specialized medical device used for administering liquid medications, nutrients, or fluids directly into the gastrointestinal tract, typically through a feeding tube. This syringe is specifically designed with features such as accurate volume measurement, compatibility with enteral feeding tubes, and safety mechanisms to prevent accidental disconnection or leakage.
The growth of the enteral syringe market is driven by poverty, inadequate access to nutritious food, chronic illnesses, and aging populations contribute to the rising incidence of malnutrition cases. Enteral syringes play a crucial role in delivering essential nutrients directly into the gastrointestinal tract, ensuring patients receive adequate nutrition when oral intake is insufficient or not feasible. Moreover, rise in the trend toward home healthcare is driving the market forward. With the rise in the number of patients seeking enteral medication and nutrition at home rather than admitted to hospitals, the demand for user-friendly enteral syringes is growing. Thus, manufacturers are producing syringes that are easy to use and set compatible with home enteral feeding equipment.
However, stringent governmental regulations pose a restraint to the growth of the market growth. Regulatory authorities impose strict standards and approval processes for medical devices, including enteral syringes, to ensure safety, efficacy, and quality. Contrarily, the development of advanced feeding devices with lesser side effects presents an opportunity for the growth of the market. Innovations in enteral syringe design, materials, and functionalities aim to enhance patient comfort, reduce complications, and improve treatment outcomes. For instance, the development of enteral syringes, by Baxter International Inc., with ergonomic designs, precise dosage control mechanisms, and anti-reflux features can minimize the risk of aspiration and tube-related complications, making enteral feeding safer and more efficient.
Segmentation Overview
The enteral syringe market is segmented into type, age group, end user, and region. Depending on the type, the market is bifurcated into reusable and disposable. According to age group, it is divided into adults and pediatrics. According to end user, the market is classified into hospitals, ambulatory surgical centers (ASCS), and home care. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Competitive Scenario
The major players operating in the enteral syringe market include Fresenius SE & Co. KGaA, Boston Scientific Corporation, Danone, Cook Medical, Inc., Cardinal Health Inc., Becton, Dickinson and Company, Moog Inc., B. Braun Melsungen AG, Owens & Minor, Inc., and Nestlé S.A. Other players in the enteral syringe market include Medtronic PLC, Medline Industries LP, Kentec Medical Inc., Thermo Fisher Scientific Inc, and Baxter International Inc. These players have employed several strategies such as mergers & acquisitions, partnerships, collaboration, and continuous product development and innovation to strengthen their position in the competitive environment.
Key Market Segments
By Type
Reusable
Disposable
By Age Group
Adults
Pediatrics
By End User
Hospitals
Ambulatory Surgical Centers
Homecare
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Fresenius SE & Co. KGaA
Boston Scientific Corporation
Danone
Cook Medical, Inc.
Cardinal Health Inc.
Becton, Dickinson and Company
Moog Inc.
B. Braun Melsungen AG
Owens & Minor, Inc.
Nestlé S.A.
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities
- CHAPTER 4: ENTERAL SYRINGE MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Reusable
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Disposable
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: ENTERAL SYRINGE MARKET, BY AGE GROUP
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Age Group
- 5.2. Adults
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Pediatrics
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: ENTERAL SYRINGE MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Ambulatory Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Homecare
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: ENTERAL SYRINGE MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Age Group
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Enteral Syringe Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Age Group
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Enteral Syringe Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Age Group
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Enteral Syringe Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Age Group
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Age Group
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Enteral Syringe Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Age Group
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Enteral Syringe Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Age Group
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Enteral Syringe Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Age Group
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Enteral Syringe Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Age Group
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Enteral Syringe Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Age Group
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Enteral Syringe Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Age Group
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Age Group
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Enteral Syringe Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Age Group
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Enteral Syringe Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Age Group
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Enteral Syringe Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Age Group
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia Enteral Syringe Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Age Group
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Enteral Syringe Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Age Group
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Enteral Syringe Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Age Group
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Age Group
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Enteral Syringe Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Age Group
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Enteral Syringe Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Age Group
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Enteral Syringe Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Age Group
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Enteral Syringe Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Age Group
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Fresenius SE And Co. KGaA
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Boston Scientific Corporation
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Danone
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Cook Medical, Inc.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Cardinal Health Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Becton, Dickinson And Company
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Moog Inc.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. B. Braun Melsungen AG
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Owens And Minor, Inc.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Nestlé S.A.
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL ENTERAL SYRINGE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 2. ENTERAL SYRINGE MARKET FOR REUSABLE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 3. ENTERAL SYRINGE MARKET FOR DISPOSABLE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 4. GLOBAL ENTERAL SYRINGE MARKET, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 5. ENTERAL SYRINGE MARKET FOR ADULTS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 6. ENTERAL SYRINGE MARKET FOR PEDIATRICS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 7. GLOBAL ENTERAL SYRINGE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 8. ENTERAL SYRINGE MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 9. ENTERAL SYRINGE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 10. ENTERAL SYRINGE MARKET FOR HOMECARE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 11. ENTERAL SYRINGE MARKET, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 12. NORTH AMERICA ENTERAL SYRINGE, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 13. NORTH AMERICA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 14. NORTH AMERICA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 15. NORTH AMERICA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 16. U.S. ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 17. U.S. ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 18. U.S. ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 19. CANADA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 20. CANADA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 21. CANADA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 22. MEXICO ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 23. MEXICO ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 24. MEXICO ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 25. EUROPE ENTERAL SYRINGE, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 26. EUROPE ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 27. EUROPE ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 28. EUROPE ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 29. GERMANY ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 30. GERMANY ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 31. GERMANY ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 32. FRANCE ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 33. FRANCE ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 34. FRANCE ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 35. UK ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 36. UK ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 37. UK ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 38. ITALY ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 39. ITALY ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 40. ITALY ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 41. SPAIN ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 42. SPAIN ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 43. SPAIN ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 44. REST OF EUROPE ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 45. REST OF EUROPE ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 46. REST OF EUROPE ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 47. ASIA-PACIFIC ENTERAL SYRINGE, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 48. ASIA-PACIFIC ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 49. ASIA-PACIFIC ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 50. ASIA-PACIFIC ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 51. JAPAN ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 52. JAPAN ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 53. JAPAN ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 54. CHINA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 55. CHINA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 56. CHINA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 57. INDIA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 58. INDIA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 59. INDIA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 60. AUSTRALIA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 61. AUSTRALIA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 62. AUSTRALIA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 63. SOUTH KOREA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 64. SOUTH KOREA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 65. SOUTH KOREA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 66. REST OF ASIA-PACIFIC ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 67. REST OF ASIA-PACIFIC ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 69. LAMEA ENTERAL SYRINGE, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 70. LAMEA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 71. LAMEA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 72. LAMEA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 73. BRAZIL ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 74. BRAZIL ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 75. BRAZIL ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 76. SAUDI ARABIA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 77. SAUDI ARABIA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 78. SAUDI ARABIA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 79. SOUTH AFRICA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 80. SOUTH AFRICA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 81. SOUTH AFRICA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 82. REST OF LAMEA ENTERAL SYRINGE, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 83. REST OF LAMEA ENTERAL SYRINGE, BY AGE GROUP, 2024 - 2033 ($MILLION)
- TABLE 84. REST OF LAMEA ENTERAL SYRINGE, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 85. FRESENIUS SE AND CO. KGAA: KEY EXECUTIVES
- TABLE 86. FRESENIUS SE AND CO. KGAA: COMPANY SNAPSHOT
- TABLE 87. FRESENIUS SE AND CO. KGAA: OPERATING SEGMENTS
- TABLE 88. FRESENIUS SE AND CO. KGAA: PRODUCT PORTFOLIO
- TABLE 89. FRESENIUS SE AND CO. KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 91. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 92. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 93. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 94. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95. DANONE: KEY EXECUTIVES
- TABLE 96. DANONE: COMPANY SNAPSHOT
- TABLE 97. DANONE: OPERATING SEGMENTS
- TABLE 98. DANONE: PRODUCT PORTFOLIO
- TABLE 99. DANONE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. COOK MEDICAL, INC.: KEY EXECUTIVES
- TABLE 101. COOK MEDICAL, INC.: COMPANY SNAPSHOT
- TABLE 102. COOK MEDICAL, INC.: OPERATING SEGMENTS
- TABLE 103. COOK MEDICAL, INC.: PRODUCT PORTFOLIO
- TABLE 104. COOK MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. CARDINAL HEALTH INC.: KEY EXECUTIVES
- TABLE 106. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
- TABLE 107. CARDINAL HEALTH INC.: OPERATING SEGMENTS
- TABLE 108. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
- TABLE 109. CARDINAL HEALTH INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 111. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 112. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 113. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 114. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 115. MOOG INC.: KEY EXECUTIVES
- TABLE 116. MOOG INC.: COMPANY SNAPSHOT
- TABLE 117. MOOG INC.: OPERATING SEGMENTS
- TABLE 118. MOOG INC.: PRODUCT PORTFOLIO
- TABLE 119. MOOG INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 120. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
- TABLE 121. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
- TABLE 122. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
- TABLE 123. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
- TABLE 124. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 125. OWENS AND MINOR, INC.: KEY EXECUTIVES
- TABLE 126. OWENS AND MINOR, INC.: COMPANY SNAPSHOT
- TABLE 127. OWENS AND MINOR, INC.: OPERATING SEGMENTS
- TABLE 128. OWENS AND MINOR, INC.: PRODUCT PORTFOLIO
- TABLE 129. OWENS AND MINOR, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 130. NESTLé S.A.: KEY EXECUTIVES
- TABLE 131. NESTLé S.A.: COMPANY SNAPSHOT
- TABLE 132. NESTLé S.A.: OPERATING SEGMENTS
- TABLE 133. NESTLé S.A.: PRODUCT PORTFOLIO
- TABLE 134. NESTLé S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL ENTERAL SYRINGE MARKET SEGMENTATION
- FIGURE 2. GLOBAL ENTERAL SYRINGE MARKET
- FIGURE 3. SEGMENTATION ENTERAL SYRINGE MARKET
- FIGURE 4. TOP INVESTMENT POCKET IN ENTERAL SYRINGE MARKET
- FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 8. LOW THREAT OF SUBSTITUTION
- FIGURE 9. HIGH COMPETITIVE RIVALRY
- FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALENTERAL SYRINGE MARKET
- FIGURE 11. GLOBAL ENTERAL SYRINGE MARKET SEGMENTATION, BY TYPE
- FIGURE 12. ENTERAL SYRINGE MARKET FOR REUSABLE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 13. ENTERAL SYRINGE MARKET FOR DISPOSABLE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 14. GLOBAL ENTERAL SYRINGE MARKET SEGMENTATION, BY AGE GROUP
- FIGURE 15. ENTERAL SYRINGE MARKET FOR ADULTS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 16. ENTERAL SYRINGE MARKET FOR PEDIATRICS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 17. GLOBAL ENTERAL SYRINGE MARKET SEGMENTATION, BY END USER
- FIGURE 18. ENTERAL SYRINGE MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 19. ENTERAL SYRINGE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 20. ENTERAL SYRINGE MARKET FOR HOMECARE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 25. COMPETITIVE DASHBOARD
- FIGURE 26. COMPETITIVE HEATMAP: ENTERAL SYRINGE MARKET
- FIGURE 27. TOP PLAYER POSITIONING, 2023
- FIGURE 28. FRESENIUS SE AND CO. KGAA: NET SALES, 2021-2023 ($MILLION)
- FIGURE 29. FRESENIUS SE AND CO. KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 30. FRESENIUS SE AND CO. KGAA: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 31. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($MILLION)
- FIGURE 32. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. DANONE: NET SALES, 2021-2023 ($MILLION)
- FIGURE 35. DANONE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. DANONE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. COOK MEDICAL, INC.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 38. COOK MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. COOK MEDICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. CARDINAL HEALTH INC.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 41. CARDINAL HEALTH INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. CARDINAL HEALTH INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($MILLION)
- FIGURE 44. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. MOOG INC.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 47. MOOG INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. MOOG INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. B. BRAUN MELSUNGEN AG: NET SALES, 2021-2023 ($MILLION)
- FIGURE 50. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. OWENS AND MINOR, INC.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 53. OWENS AND MINOR, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. OWENS AND MINOR, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. NESTLé S.A.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 56. NESTLé S.A.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. NESTLé S.A.: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook